Current Opinion in Infectious Diseases was launched in 1988. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of infectious diseases is divided into 11 sections that are reviewed once a year. Each section is assigned to a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Matteo Bassetti is Head of the Infectious Diseases Clinic of the Policlinico San Martino University Hospital in Genoa and Full Professor of Infectious Diseases of the University of Genoa, Italy. Dr Bassetti studied at the University of Genoa School of Medicine and continued his medical education at the Yale University School of Medicine, New Haven, USA with an Infectious Diseases fellowship.
Dr Bassetti is Chair of the Critically Ill Study Group of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), president of the Italian Society of Anti-infective Therapy (SITA) and member of executive committee for the battle against antimicrobial resistance of the Italian Minister of Health (PNCAR). He is member-elected (2018-2022) of International Council of the Immunocompromised Host Society (ICHS). From 2019, he is member of the council of International Sepsis Forum (ISF). He serves on the editorial board of several prestigious international journals. He is author or co-author of 750 papers (H index 85; 30000 citations) published in International peer-review journals and several chapter's book on antibiotic therapy, fungal infections, antimicrobial resistances, infections in immunocompromised patients and critically ill patients.
Wei Shen Lim
Professor Wei Shen Lim is consultant respiratory physician at Nottingham University Hospitals NHS Trust and Honorary Professor of Respiratory Medicine, University of Nottingham, UK. He is Chair of COVID-19 Immunisation on the Joint Committee of Vaccination and Immunisation (JCVI), UK and a member of various national advisory groups including the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) to the Chief Medical Officer for England.
He was Chief Investigator of the hibernated ASAP Trial of Dexamethasone in Pandemic Influenza (2012-2022), and co-led the evaluation of Dexamethasone for COVID-19 in the RECOVERY TRIAL He has been involved with the British Thoracic Society (BTS) and the National Institute for Health and Care Excellence (NICE) in the development of various national clinical management guidelines for acute respiratory infections including community acquired pneumonia, pandemic influenza and COVID-19.
He developed the CURB-65 severity assessment score for community acquired pneumonia and the BTS community acquired pneumonia care bundle. He was awarded the British Thoracic Society Meritorious Award in 2016 for contributions towards respiratory infections, and in 2021 the Moxon Medal by the Royal College of Physicians (London).